PRIMACOR Drug Patent Profile

✉ Email this page to a colleague

When do Primacor patents expire, and when can generic versions of Primacor launch?

Primacor is a drug marketed by Sanofi Aventis Us and is included in two NDAs.

The generic ingredient in PRIMACOR is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Primacor

A generic version of PRIMACOR was approved as milrinone lactate by FRESENIUS KABI USA on May 28^th, 2002.

Try a Trial

Summary for PRIMACOR

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	131
Clinical Trials:	11
Patent Applications:	5,082
Formulation / Manufacturing:	see details
DailyMed Link:	PRIMACOR at DailyMed

Drug patent expirations by year for PRIMACOR

Recent Clinical Trials for PRIMACOR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mahidol University	Phase 2
Zagazig University	Phase 4
Lipscomb University	Phase 1

See all PRIMACOR clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for PRIMACOR

C01CE	Phosphodiesterase inhibitors
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for PRIMACOR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sanofi Aventis Us	PRIMACOR	milrinone lactate	INJECTABLE;INJECTION	019436-001	Dec 31, 1987		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-003	Aug 9, 1994		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-001	Aug 9, 1994		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-002	Aug 9, 1994		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-004	Aug 9, 1994		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PRIMACOR

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	PRIMACOR	milrinone lactate	INJECTABLE;INJECTION	019436-001	Dec 31, 1987	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PRIMACOR

See the table below for patents covering PRIMACOR around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
United Kingdom	2131421	PYRIDINYL ETHENYL ALKYL KETONES	⤷ Try a Trial
Greece	71608		⤷ Try a Trial
Sweden	8008252		⤷ Try a Trial
Finland	854740		⤷ Try a Trial
Canada	1155852	6-ALKYL-5-(PYRIDINYL)-3-SUBSTITUANT-2(1H)-PYRIDINONES, UTILES COMME AGENTS CARDIOTONIQUES, ET LEUR PREPARATION (6-ALKYL-5-(PYRIDINYL)-3-SUBSTITUTED-2(1H)-PYRIDINONES, USEFUL AS CARDIOTONIC AGENTS AND THEIR PREPARATION)	⤷ Try a Trial
Belgium	886336		⤷ Try a Trial
South Africa	8102026		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for PRIMACOR

Recent Clinical Trials for PRIMACOR

Anatomical Therapeutic Chemical (ATC) Classes for PRIMACOR

Make Better Decisions: Try a trial or see plans & pricing